People who come from obesity like Wegovy and Mounjaro should make checks for at least a year to make sure they do not postpone the weight, says new advice for the NHS.
It is not uncommon for people to find most of what they lose once they have stopped treatment, shows of experience.
The advice, of the Nice health assessment organization, warn weight management is a long -term trip, not a short -term solution.
Patients may need additional support and a plan to find out how to stay with their new weight, like eating healthy and hit the gymnasium or make walks, he said.
In England alone, obesity affects approximately one in four adults.
It is estimated that 1.5 million people are on jabs of weight loss in the United Kingdom, but the vast majority pay them in private and will therefore not be eligible for the support of the NHS when they leave treatment.
Wegovy (semaglutide) is already available on the prescription NHS, but only for those who need it most (with health problems because of their weight and a high BMI) for a period of two years.
About 240,000 people are expected to be offered mounjaro (shooting) over the next three years. There is currently no time specified to be prescribed the drug.
Both drugs help reduce appetite and can cause life loss that changes their life. They are prescribed alongside programs that support healthy weight loss thanks to changes to food and physical activity.
In a Wegovy medication trial, patients found two thirds of their original weight once they came out of injections. It is a similar story for those on Mounjaro.
New advice from Nice, the National Institute for Health and Excellence of Care, encourages patients to build long-term behavioral habits, to use self-monitoring tools and to rely on broader support “online communities to family interventions and local activities”.
Professor Jonathan Benger of Nice said: “Successful management of weight does not stop when drugs stop or when someone ends a behavior program.
“We know that the transition period after treatment is crucial and that people need structured support to maintain the positive changes they have made.”
Professor Kamila Hawthorn of the Royal College of GPS said: “There is no unique approach to fighting obesity – what works for a patient will probably not work for another.
“We must also see greater concentration on prevention, preventing people from becoming overweight in the first place so that they do not need medical intervention later.”
Obesity can cause difficulty people in their daily lives and put them more at risk of serious health problems, such as heart disease, type 2 diabetes and certain types of cancer.
